Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DR. McCoy want's to know "What in the name of sanity is going on?"
NLST is ensconced* nicely above &1.00
*definition: to position firmly or comfortably.
Correction NLST will report AFTER market close
I respect your decidesion.
Monday March 1, NLST will report, before market opens.
Was Friday's price action a precursor of good news?
You have hit an another home run.
Thanks for exposing the REAL world
Officially Chairman Xiben
The article date on the story. July 8. 2020.
Looks like the rush has been put on hold.
After reading the Kitco news release this morning I can't help wondering how long before U.S. production comes on line. and what's to recycle?
From the article, U.S. is not even mentioned as a contributor to world Li production in 2020.
Excerpt from Kitco News...
"Several established lithium operations postponed
capacity expansion plans.
Junior mining operations in Australia and Canada
ceased production altogether>"
"BRLL is not abandoning lithium, it's still recycling, developing and producing lithium."
Sorry to disagree with you but BRLL has not done any thing to this date.
It simply says "We have plans, and no money, yet.
"I'll call them and ask WTF is up".
One thing they'll tell you "It sure ain't the share price"
Up .06 in premarket per td amertrade.
Is this possible?
BRLL stock is like a Roach Motel: You can get in, but you can't get out.
Pre market trading is up to the brokers and market makers.
If they want it, it can happen. Per investapida (sp).
From ZH:
China Threatens To Hobble US Defense Industry By Limiting Export Of Rare-Earth Metals
BY TYLER DURDEN
TUESDAY, FEB 16, 2021
China has been quietly exploring the economic damage it could inflict to US and European companies - including defense contractors - if they were to impose export 'restrictions' on 17 rare-earth materials, according to a report in the Financial Times.
Notably, the US government relies on these rare earths for the manufacture of F-35 jets and other sophisticated weaponry, which use them for critical components such as electrical power systems and magnets.
From another board-sounds right to me:
Volume has been slowly increasing over the past week and someone(s) who may be involved with or knows about the R&D may be gradually buying IMO. I think an update or PR is coming within the next 4-6 weeks. It takes time for these companies to even get the setup accomplished to check out new tech. You have to figure out and obtain the necessary equipment, develop procedures, then test and summarize the results. It's tough to get all that done in 4 months but feasible at 6 months considering the urgency of the situation.
Regardless of your time frame, the here and now is what matters.
What color lipstick do you use for this pig?
"No reason BRLL couldn't be at 20 dollars a share"
Best laugh of the day!
The only thing that is a fact is this venture takes MONEY of which neither party HAVE!
AM I correct that some time back graphine was mentioned as integral part the lithium battery?
The lithium battery topic is all the current rage. If so, it's time for GPHBF to play their option.
Premarket .888 on TD Ameritrade
People are forgetting the news from when the patent was approved.
If everyone may not need the vaccine, per the rapid test, then the availability of the vaccine can be streached out to those who do need the vaccine.
Post #13189
The patent, according to Dr. Jonathan Faro, chief medical officer for NanoLogix, has wide-ranging implications, from “those who would like to determine if a convalescent serum has effective antibodies capable of neutralizing the virus” to “those who would like to know if an individual is contagious, or if they have gotten over the virus and can now go back to work.”
“This has implications for those who get the vaccine, but they would like to know if they seroconverted and may safely return to work,” Faro wrote."
"The patent also impacts people ready to get a vaccine, but want to make sure they are not an asymptomatic carrier and don’t need it, and medications and treatment strategies.
Has the FDA declined approval? Extreme volume and price drop suggests so.
On November 23, 2020, American Lithium Minerals, Inc. (“AMLM”) entered into an Earn-In Agreement with Altair
International Corp. (“Altair”). under which Altair must make total payments of $75,000 to obtain a 10% undivided interest
in 63 unpatented placer mining claims comprised of approximately 1,260 acres in Nevada, commonly known as the
Stonewall Flat Lithium Project. The $75,000 has been paid by Altair. Altair has the option to increase its ownership
interest by an additional 50% by a total payment of $1,300,648 for exploration and development costs as follows:
$100,648 within year one for an additional 10/%, $600,000 in year two for an additional 20% and $600,000 in year three
for an additional 20% ownership interest. The foregoing description of the Earn-In Agreement does not purport to be
complete and is qualified in its entirety by reference to the Agreement which is filed as Exhibit A to this Supplemental
Information Report.
Another hit story for PCR test results.
Open the link to get the latest from WHO
https://www.zerohedge.com/economics/right-cue-biden-who-admits-high-cycle-pcr-tests-produce-massive-covid-false-positives
From another board:
GPHBF has a "blocker" on the stock. Can anyone define this blocker label?
See the whole post........
"There is now a blocker on this stock on the US market. What does that tell you regarding the future price of this stock. Time to load the boat, I expect 50 cents to a dollar by 01/31/21."
This sounds positive for NNLX and their novel test
https://www.zerohedge.com/covid-19/fda-admits-pcr-tests-give-false-results-
The FDA today joined The WHO and Dr.Fauci in admitting there is a notable risk of false results from the standard PCR-Test used to define whether an individual is a COVID "Case" or not.
Back in 2017 nlst was mentioned as a long shot component supplier to bitcoin miners, (CPU) through AMD?.
Bitcoin miners are in short supply per ZH article 1 3, 2021.
Possibly a resurgence of interest for NLST?
You say "Ill have the Peking Duck" well, make mine baked Alaska, with a sprinkle of gold dust
This is from NNLX home page titled "Our Technology."
Simply states the technology functions without PCR equiptment.
NanoLogix technology provides live-cell rapid detection
and identification dramatically faster than Flow Cytometry
and traditional Petri culture methods. Additionally, in contrast
to other fast methods such as
Polymerase Chain Reaction (PCR), our technology does not require
large investments in equipment or personnel training.
Our N-Assay and new Rapid Virus Assay technologies
are simple, easy to use and portable.
They provide a more accurate, cost-effective
alternative to PCR and Flow Cytometry.
Quantitative, Live-Cell and Rapid Virus Results
In the past decades, DNA analysis has emerged
as a popular, yet expensive, trend to speed up
microorganism diagnostics. Other disadvantages
of this type of analysis (also known as PCR)
include a failure of the technology to return live-cell results.
Instead, these tests are only able to detect
for the presence of the organism in a sample.
Technicians using PCR are unable
to determine the viability of the microorganisms
from these results.
Results using NanoLogix technology,
by contrast, are fast and can detect whether or not
a microorganism found in the sample is alive,
and therefore a viable health threat.
This distinction between live and dead cells
is a crucial requirement in the identification of
pathogenic microorganisms. It is the reason
many laboratories continue to insist on live-cell
results, despite the longer wait for results.
Is there some hope that the statement from EPA gives some relief to NAK?
Below is what the ROD said
"The agency says the plan submitted by the Pebble Partnership to deal with the project's waste "does not comply with Clean Water Act guidelines"
Coming back slowly, .15 is welcome to see.
Today's message from Mr. Barhhizer, as posted, has caused a flurry of
disappointment as reflected in the share price drop but there are prospects for more developments that the patient can bring. Namely FDA approval and EAU (emergency approval use). I'm holding.
NanoLogix, a small, innovative, historically under-capitalized biotechnology company, has developed this technology through funding and research by the CEO and two Directors, with a keen awareness of the importance of this development relative to the current pandemic. The Company has also benefited from the assistance of a small number of long-term shareholders with lasting faith in the Company’s work and potential. Gratitude is expressed to all involved for their contributions. Thanks also to Gwen Acker Wood, IP Attorney, for her superb attention to detail and experience in patent work.
Bret Barnhizer
Nanologix Incorporated
I have chosen to review my choices.
At this stage of the game NNLX can beat the pants off NAK.
FROM: November, 2011 Fastest TB test in 4 days
NanoLogix Technology Delivers Live Tuberculosis (TB) Detection Results in a Revolutionary 4 Days versus Traditional 21 Days
Third Party Research Study Results Are 500% Faster Than Conventional Tests
November 01, 2011 09:31 AM Eastern Daylight Time
HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix (Pink Sheets: NNLX), an innovator in the rapid detection, identification and antibiotic sensitivity determination of live bacteria announced today third-party results for detecting live Mycobacterium tuberculosis (TB) in a revolutionary time of 4 days with its BNP (BioNanoPore) technology. The advanced culture test results with the NanoLogix BNP technology are at least 500% faster than the 21-day standard for live TB culture detection. Additionally, other test methods for tuberculosis are expensive, labor intensive and cannot determine if a microbe found in a sample is living or dead. The NanoLogix technology provides a significant advantage over conventional methods for detecting TB in developing regions where medical resources are scarce and TB infections are rampant.
“We are ecstatic over the third-party 4-day TB test results”
Tweet this
The 4-day TB results are a part of a lab research study conducted by a well-respected third party laboratory. The organization maintains anonymity until research data is published in a leading scientific journal.
"We are ecstatic over the third-party 4-day TB test results," said Bret Barnhizer, CEO of NanoLogix. "Typically, physicians must wait at least 21 days to determine if a patient should be put on antibiotics for TB. With an annual death toll of well over one million from this devastating disease, providing definitive, viable determination of TB in 4 days is a true game-changer."
The World Health Organization estimates that roughly one third of the world's population is infected with TB, either in an active or latent form. Highly contagious, active tuberculosis infections commonly attack the lungs and have a 50% mortality rate. In recent decades, the misdiagnosis and mismanagement of TB infections have led to a number of antibiotic-resistant strains, such as Mutli-Drug Resistant Tuberculosis and Extensively Drug Resistant TB.
Because of its slow growing nature, speeding up the definitive diagnosis of live-cell TB detection has been a consistent challenge for the medical industry. While techniques such as X-ray examinations, smear tests and DNA sequencing have provided alternatives to 21 day culture results, their inability to differentiate between the simple presence of a bacteria and a true active infection have left them unable to provide a comprehensive tool for fighting TB.
"By making the 'gold standard' method of culturing a faster process, our technology has the potential of providing the medical community with an extremely rapid, accurate, affordable and definitive culture-based TB test," continued Barnhizer. "With NanoLogix, physicians will soon have the opportunity to detect live TB faster, administer antibiotics properly, and monitor the efficacy of antibiotics in a close to real-time mode. This will provide the opportunity to reduce the prevalence of TB infections around the world."
NanoLogix Technology Granted Chinese Patent
In a milestone for the company, NanoLogix is pleased to announce it has been granted a foundational patent by China for its BNC (BioNanoChannel) detection technology. In addition to patents pending with the USPTO, the company has multiple patent applications pending in China, India, Brazil, Japan, Russia and Europe for their BNC, BNP and BNF (BioNanoFilter) detection technologies.
Come for the pennies, stay for the dollars!
Is this too good to be true?
From Tribune article:
The patent, according to Dr. Jonathan Faro, chief medical officer
for NanoLogix, has wide-ranging implications, from
“those who would like to determine if a convalescent
serum has effective antibodies capable of neutralizing
the virus” to “those who would like to know
if an individual is contagious, or if they have gotten
over the virus and can now go back to work.”
“This has implications for those who
get the vaccine, but they would like to know
if they seroconverted and may safely return to work,” Faro wrote.
The patent also impacts people ready
to get a vaccine, but want to make sure
the are not an asymptomatic carrier and
don’t need it, and medications and treatment strategies.
If this reject is based on the company's ability to deal with the project's waste then there will be a concerted effort to find a viable technical solution. Watch for the appeal in 60 days.
"The agency says the plan submitted by the Pebble Partnership to deal with the project's waste "does not comply with Clean Water Act guidelines"
Got filled @ .149
Now NNLX is knockin' at 11's door.